Future directions in vitamin D and cardiovascular research

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 7, 2012, Pages 541-546

  Zittermann, A ^a   Borgermann J ^a   Gummert, J F ^a   Pilz, S ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

1,25(OH)2D; 25(OH)D; 25 Hydroxyvitamin D,1,25 dihydroxyvitamin D; Cardiovascular disease; DHCR7; Gene polymorphisms; Hypercalcaemia; Physical activity; UVB; Vitamin D

Indexed keywords

EID: 84862133547     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2012.02.004     Document Type: Short Survey

References (48)

1. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Stuck A.E., Staehelin H.B., Orav E.J., et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009, 169:551-561.
2. Kobylinski S., Häfer B., Kohde G. Correlative pathologic studies on the role of vitamin D in vascular calcinosis in childhood. Zentralbl Allg Pathol 1984, 129:137-147. [In German].
3. Seelig M.S. Vitamin D and cardiovascular, renal, and brain damage in infancy and childhood. Ann N Y Acad Sci 1969, 147:539-582.
4. Scragg R. Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol 1981, 10:337-341.
5. Zittermann A., Schleithoff S.S., Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005, 94:483-492.
6. Zittermann A., Gummert J.F. Sun, vitamin D, and cardiovascular disease. J Photochem Photobiol B 2010, 101:124-129.
7. Zittermann A., Frisch S., Berthold H.K., Götting C., Kuhn J., Kleesiek K., et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009, 89:1321-1327.
8. Harris R.A., Pedersen-White J., Guo D.H., Stallmann-Jorgensen I.S., Keeton D., Huang Y., et al. Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 2011, 24:557-562.
9. Witham M.D., Dove F.J., Sugden J.A., Doney A.S., Struthers A.D. The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. Nutr Metab Cardiovasc Dis 2010 Dec 29, [Epub ahead of print].
10. Zittermann A., Gummert J.F. Nonclassical vitamin D actions. Nutrients 2010, 2:408-425.
11. Wang L., Manson J.E., Song Y., Sesso H.D. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010, 152:315-323.
12. Avenell A., Maclennan G.S., Jenkinson D.J., McPherson G.C., McDonald A.M., Pant P.R., The RECORD Trial Group, et al. Long-term Follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D3 and/or calcium (RECORD trial). J Clin Endocrinol Metab 2011 Nov 23, [Epub ahead of print].
13. Zittermann A. The estimated benefits of vitamin D for Germany. Mol Nutr Food Res 2010, 54:1164-1171.
14. Hyppönen E., Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007, 85:860-868.
15. Zittermann A., Iodice S., Pilz S., Grant W.B., Bagnardi V., Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012, 95:91-100.
16. Laguardia S.P., Dockery B.K., Bhattacharya S.K., Nelson M.D., Carbone L.D., Weber K.T. Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure. Am J Med Sci 2006, 332:112-118.
17. Zittermann A., Fuchs U., Kuhn J., Dreier J., Schulz U., Gummert J.F., et al. Parameters of mineral metabolism predict midterm clinical outcome in end-stage heart failure patients. Scand Cardiovasc J 2011, 45:342-348.
18. Ronco C., Cozzolino M. Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes. Heart Fail Rev 2011 Feb 13, [Epub ahead of print].
19. Bhattacharya S.K., Ahokas R.A., Carbone L.D., Newman K.P., Gerling I.C., Sun Y., et al. Macro- and micronutrients in African-Americans with heart failure. Heart Fail Rev 2006, 11:45-55.
20. Steingrimsdottir L., Gunnarsson O., Indridason O.S., Franzson L., Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005, 294:2336-2341.
21. Zia A.A., Komolafe B.O., Moten M., Ahokas R.A., McGee J.E., William R.E., et al. Supplemental vitamin D and calcium in the management of African Americans with heart failure having hypovitaminosis D. Am J Med Sci 2011, 341:113-118.
22. van Groningen L., Opdenoordt S., van Sorge A., Telting D., Giesen A., de Boer H. Cholecalciferol loading dose guideline for vitamin D-deficient adults. Eur J Endocrinol 2010, 162:805-811.
23. Teng M., Wolf M., Ofsthun M.N., Lazarus J.M., Hernán M.A., Camargo C.A., et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005, 16:1115-1125.
24. Vacek J.L., Vanga S.R., Good M., Lai S.M., Lakkireddy D., Howard P.A. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 2011 Nov 7, [Epub ahead of print].
25. Hyppönen E., Läärä E., Reunanen A., Järvelin M.R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001, 358:1500-1503.
26. D'Agostino R.B. Propensity scores in cardiovascular research. Circulation 2007, 115:2340-2343.
27. Kuss O., Legler T., Börgermann J. Treatments effects from randomized trials and propensity score analyses were similar in similar populations in an example from cardiac surgery. J Clin Epidemiol 2011, 64:1076-1084.
28. Mangano D.T., Tudor I.C., Dietzel C. Multicenter study of Perioperative Ischemia research group; Ischemia research and Education Foundation. the risk associated with aprotinin in cardiac surgery. N Engl J Med 2006, 354:353-365.
29. Fergusson D.A., Hébert P.C., Mazer C.D., Fremes S., MacAdams C., Murkin J.M., BART Investigators, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008, 358:2319-2331.
30. Javaid M.K., Crozier S.R., Harvey N.C., Gale C.R., Dennison E.M., Boucher B.J., Princess Anne Hospital Study Group, et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 2006, 367:36-43.
31. Zittermann A., Schleithoff S.S., Frisch S., Götting C., Kuhn J., Koertke H., et al. Circulating calcitriol concentrations and total mortality. Clin Chem 2009, 55:1163-1170.
32. Zittermann A., Schleithoff S.S., Götting C., Fuchs U., Kuhn J., Kleesiek K., et al. Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation 2009, 87:118-124.
33. Zochling J., Chen J.S., Seibel M., Schwarz J., Cameron I.D., Cumming R.G., et al. Calcium metabolism in the frail elderly. Clin Rheumatol 2005, 24:576-582.
34. Zittermann A., Schleithoff S.S., Gotting C., Dronow O., Fuchs U., Kuhn J., et al. Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail 2008, 10:321-327.
35. Alsafwah S., Laguardia S.P., Nelson M.D., Battin D.L., Newman K.P., Carbone L.D., et al. Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure. Am J Med Sci 2008, 335:292-297.
36. Tomaschitz A., Pilz S., Ritz E., Grammer T., Drechsler C., Boehm B.O., et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the ludwigshafen risk and cardiovascular health (LURIC) study. Clin Chim Acta 2010, 411:1354-1360.
37. Hagström E., Hellman P., Larsson T.E., Ingelsson E., Berglund L., Sundström J., et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009, 119:2765-2771.
38. Kamycheva E., Sundsfjord J., Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the tromsø study. Eur J Cardiovasc Prev Rehabil 2004, 11:69-74.
39. Gutiérrez O.M. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis. Clin J Am Soc Nephrol 2010, 5:1710-1716.
40. Gutiérrez O.M., Mannstadt M., Isakova T., Rauh-Hain J.A., Tamez H., Shah A., et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008, 359:584-592.
41. IOM (Institute of Medicine) Dietary reference intakes for calcium and vitamin D 2011, The National Academies Press, Washington, DC.
42. Souberbielle J.C., Body J.J., Lappe J., Plebani M., Shoenfeld Y., Wang T.J., et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practise. Autoimmun Rev 2010, 9:709-715.
43. Vieth R., Fraser D., Kooh S.W. Low dietary calcium reduces 25-hydroxycholecalciferol in plasma of rats. J Nutr 1987, 117:914-918.
44. Wang T.J., Zhang F., Richards J.B., Kestenbaum B., van Meurs J.B., Berry D., et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010, 376:180-188.
45. Bailey R., Cooper J.D., Zeitels L., Smyth D.J., Yang J.H., Walker N.M., et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007, 56:2616-2621.
46. Schlingmann K.P., Kaufmann M., Weber S., Irwin A., Goos C., John U., et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011, 365:410-421.
47. Andersen R., Brot C., Ovesen L. Towards a strategy for optimal vitamin D fortification (OPTIFORD). Nutr Metab Cardiovasc Dis 2001, 11(4 Suppl):74-77.
48. Zittermann A., Sabatschus O., Jantzen S., Platen P., Danz A., Dimitriou T., et al. Exercise-trained young men have higher calcium absorption rates and plasma calcitriol levels compared with age-matched sedentary controls. Calcif Tissue Int 2000, 67:215-219.